Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias

被引:40
作者
Gouya, L
Puy, H
Robreau, AM
Lyoumi, S
Lamoril, J
Da Silva, V
Grandchamp, B
Deybach, JC
机构
[1] Hop Louis Mourier, Fac Xavier Bichat, INSERM, U409,Ctr Francais Porphyries, F-92701 Colombes, France
[2] Fac Med Paris, F-92380 Garches, France
关键词
D O I
10.1007/s00439-003-1059-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have recently demonstrated that in an autosomal dominant porphyria, erythropoietic protoporphyria (EPP), the coinheritance of a ferrochelatase (FECH) gene defect and of a wild-type low-expressed FECH allele is generally involved in the clinical expression of EPP. This mechanism may provide a model for phenotype modulation by minor variations in the expression of the wild-type allele in the other three autosomal dominant porphyrias that exhibit incomplete penetrance: acute intermittent porphyria (AIP), variegata porphyria (VP) and hereditary coproporphyria (HC), which are caused by partial deficiencies of hydroxy-methyl bilane synthase (HMBS), protoporphyrinogen oxidase (PPOX) and coproporphyrinogen oxidase (CPO), respectively. Given the dominant mode of inheritance of EPP, VP, AIP and HC, we first confirmed that the 200 overtly porphyric subjects (55 EPP, 58 AIP, 56 VP; 31 HC) presented a single mutation restricted to one allele (20 novel mutations and 162 known mutations). We then analysed the available single-nucleotide polymorphisms (SNPs) present at high frequencies in the general population and spreading throughout the FECH, HMBS, PPOX and the CPO genes in four case-control association studies. Finally, we explored the functional consequences of polymorphisms on the abundance of wild-type RNA, and used relative allelic mRNA determinations to find out whether low-expressed HMBS, PPOX and the CPO alleles occur in the general population. We confirm that the wild-type low-expressed allele phenomenon is usually operative in the mechanism of variable penetrance in EPP, but conclude that this is not the case in AIP and VP. For HC, the CPO mRNA determinations strongly suggest that normal CPO alleles with low-expression are present, but whether this low-expression of the wild-type allele could modulate the penetrance of a CPO gene defect in HC families remains to be ascertained.
引用
收藏
页码:256 / 262
页数:7
相关论文
共 25 条
[1]   SP-ALPHA-V/41 - A COMMON SPECTRIN POLYMORPHISM AT THE ALPHA-IV-ALPHA-V DOMAIN JUNCTION - RELEVANCE TO THE EXPRESSION LEVEL OF HEREDITARY ELLIPTOCYTOSIS DUE TO ALPHA-SPECTRIN VARIANTS LOCATED IN TRANS [J].
ALLOISIO, N ;
MORLE, L ;
MARECHAL, J ;
ROUX, AF ;
DUCLUZEAU, MT ;
GUETARNI, D ;
POTHIER, B ;
BAKLOUTI, F ;
GHANEM, A ;
KASTALLY, R ;
DELAUNAY, J .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2169-2177
[2]  
ANDERSON KE, 2001, METABOLIC BASIS INHE, V1, P2991
[3]   MOLECULAR-BASIS OF ACUTE INTERMITTENT PORPHYRIA - MUTATIONS AND POLYMORPHISMS IN THE HUMAN HYDROXYMETHYLBILANE SYNTHASE GENE [J].
ASTRIN, KH ;
DESNICK, RJ .
HUMAN MUTATION, 1994, 4 (04) :243-252
[4]   Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression [J].
Borrego, S ;
Sáez, ME ;
Ruiz, A ;
Gimm, O ;
López-Alonso, M ;
Antiñolo, G ;
Eng, C .
JOURNAL OF MEDICAL GENETICS, 1999, 36 (10) :771-774
[5]   Alternative splicing and genome complexity [J].
Brett, D ;
Pospisil, H ;
Valcárcel, J ;
Reich, J ;
Bork, P .
NATURE GENETICS, 2002, 30 (01) :29-30
[6]   Nomenclature for the description of human sequence variations [J].
den Dunnen, JT ;
Antonarakis, E .
HUMAN GENETICS, 2001, 109 (01) :121-124
[7]  
Donnelly JG, 2002, ANN CLIN LAB SCI, V32, P107
[8]  
Gouya L, 1996, AM J HUM GENET, V58, P292
[9]   The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH [J].
Gouya, L ;
Puy, H ;
Robreau, AM ;
Bourgeois, M ;
Lamoril, J ;
Da Silva, V ;
Grandchamp, B ;
Deybach, JC .
NATURE GENETICS, 2002, 30 (01) :27-28
[10]   Inheritance in erythropoietic protoporphyria: A common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation [J].
Gouya, L ;
Puy, H ;
Lamoril, J ;
Da Silva, V ;
Grandchamp, B ;
Nordmann, Y ;
Deybach, JC .
BLOOD, 1999, 93 (06) :2105-2110